| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |